GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q2 2025

SEC EDGAR SourceSEC Filings

Top Holdings43 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

CVS HEALTH CORPORATION

8.2M$565.4M15.8%$57.60+14.82%
7 qtrssince 2023-Q4
Decreased
0

TENET HEALTHCARE CORP

2.9M$515.7M14.4%$55.91+210.57%
27 qtrssince 2018-Q4
Decreased
0

GLOBAL PAYMENTS INC

4.3M$345.5M9.7%$119.82-34.69%
19 qtrssince 2020-Q4
Increased
69
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

15.8M$265.2M7.4%$14.54+15.30%
7 qtrssince 2023-Q4
Increased
65

ZOOMINFO TECHNOLOGIES INC

16.4M$165.8M4.6%$10.51-4.03%
5 qtrssince 2024-Q2
Increased
71

ALIGHT INC

24.4M$138M3.9%$7.54-28.16%
12 qtrssince 2022-Q3
Decreased
0

AMAZON.COM INC

562,874$123.5M3.5%$169.60+31.67%
10 qtrssince 2023-Q1
Decreased
0

THE CIGNA GROUP

371,893$122.9M3.4%$235.61+37.03%
27 qtrssince 2018-Q4
Decreased
0

US FOODS HOLDING CORP

1.4M$106.2M3.0%$44.14+75.05%
15 qtrssince 2021-Q4
Decreased
0

DXC TECHNOLOGY CO

5.9M$89.7M2.5%$31.11-51.68%
27 qtrssince 2018-Q4
Decreased
0

EXPEDIA GROUP INC

508,256$85.7M2.4%$119.61+42.25%
12 qtrssince 2022-Q3
Decreased
0

META PLATFORMS INC-CLASS A

115,934$85.6M2.4%$671.42+9.10%
2 qtrssince 2025-Q1
Increased
83

PAYPAL HOLDINGS INC

1M$74.8M2.1%$65.00+13.03%
2 qtrssince 2025-Q1
Decreased
0

VIATRIS INC

8.2M$73.7M2.1%$10.37-15.05%
7 qtrssince 2023-Q4
Decreased
0

UNIVERSAL HEALTH SERVICES-B

389,477$70.6M2.0%$153.20+16.02%
11 qtrssince 2022-Q4
Decreased
0

ELEMENT SOLUTIONS INC

2.8M$63.8M1.8%$21.37+6.01%
26 qtrssince 2019-Q1
Increased
53

DICKS SPORTING GOODS INC

290,532$57.5M1.6%$200.630.00%
1 qtr
New
68

KNIGHT-SWIFT TRANSPORTATION

1.2M$51.7M1.4%$49.58-9.89%
10 qtrssince 2023-Q1
Decreased
0
CARCAR
CALL

AVIS BUDGET GROUP INC

270,000$45.6M1.3%
Increased

UNITED AIRLINES HOLDINGS INC

568,862$45.3M1.3%$74.13+6.82%
2 qtrssince 2025-Q1
Increased
71
$3.6B
AUM
43
Positions
Q2 2025
Filing
Rating · 4.0
Quarterly Portfolio Change
+22%Q1'24$5.7B-11%Q2'24$5.1B+2%Q3'24$5.2B-23%Q4'24$4B+3%Q1'25$4.1B-12%Q2'25$3.6B
Activity profile
$ moved · Q2'25
New15%Increased18%Decreased39%Exited29%
Composition
Equity vs derivatives
Equity99%Puts0%Calls1%
Holding period
Avg 3.1 years
<1Q16%1-4Q9%1-2Y16%2Y+58%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $3.6B across 43 positions as of Q2 2025. Top holdings: CVS (15.8%), THC (14.4%), GPN (9.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q2 2025 Summary

Active quarter - 10 new positions, 12 exits, 11 increased. Top move: META (INCREASED, conviction 83). Portfolio: $3.6B across 43 positions.

Top holdings by portfolio weight

Total AUM$4B
CVS15.84%
THC14.45%
GPN9.68%
TEVA7.43%
GTM4.64%
ALIT3.87%
AMZN3.46%
CI3.44%
USFD2.97%
DXC2.51%
Other2.40%

Portfolio allocation by GICS sector

Sectors8
Healthcare51.61%
Technology15.39%
Industrials13.38%
Consumer Cyclical10.25%
Consumer Defensive3.01%
Communication Services2.43%
Financial Services2.12%
Basic Materials1.81%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Industrials
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record72
Conviction49
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PAYMENTS INC
Q2 2025 Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON.COM INC
Q3 2025 Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used